Lanham O'Dell & Company’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$287K Hold
869
0.08% 24
2025
Q3
$300K Sell
869
-71
-8% -$21.5K 0.1% 22
2025
Q2
$293K Buy
940
+71
+8% +$27.1K 0.12% 23
2025
Q1
$455K Hold
869
0.26% 11
2024
Q4
$440K Hold
869
0.24% 12
2024
Q3
$508K Hold
869
0.29% 11
2024
Q2
$443K Hold
869
0.25% 12
2024
Q1
$430K Buy
869
+14
+2% +$7.12K 0.22% 16
2023
Q4
$450K Hold
855
0.31% 16
2023
Q3
$431K Hold
855
0.35% 8
2023
Q2
$411K Hold
855
0.37% 9
2023
Q1
$404K Sell
855
-65
-7% -$31.4K 0.44% 10
2022
Q4
$488K Hold
920
1.06% 9
2022
Q3
$465K Hold
920
1.65% 14
2022
Q2
$473K Hold
920
2.35% 8
2022
Q1
$469K Hold
920
0.36% 10
2021
Q4
$462K Buy
+920
New +$416K 0.36% 10

Other funds holding UNH

Lanham O'Dell & Company's UNH Position: Q4 2025 in Review

Lanham O'Dell & Company held its UnitedHealth (UNH) position steady in Q4 2025 at 869 shares worth $287K. The position accounts for 0.08% of the portfolio, ranked #24.

Lanham O'Dell & Company first reported a position in UNH in Q4 2021 and has held it in 17 quarters since. The position peaked at $508K in Q3 2024. 3,296 funds tracked by Wall St. Rank hold UNH as of Q4 2025.

  • Lanham O'Dell & Company held 869 shares of UnitedHealth worth $287K as of Q4 2025.
  • Lanham O'Dell & Company left its UnitedHealth share count unchanged in Q4 2025.
  • UnitedHealth made up 0.08% of Lanham O'Dell & Company's portfolio in Q4 2025, its #24 holding.
  • Lanham O'Dell & Company first reported a position in UnitedHealth in Q4 2021 and has held it in 17 quarters since.
  • Lanham O'Dell & Company's UnitedHealth position peaked at $508K in Q3 2024.
  • 3,296 funds tracked by Wall St. Rank held UnitedHealth as of Q4 2025.

Based on Lanham O'Dell & Company's 13F filing for Q4 2025, filed 12 Jan 2026.